These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10602470)

  • 21. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
    Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
    Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of Epstein-Barr virus latent membrane protein 1 mediated by nuclear factor-kappaB on transformation and tumorigenesis of rat-1 cells].
    Zhang ZW; He ZM; Zhou M; Zhang Q; Yu YH; Chen ZC
    Ai Zheng; 2007 Feb; 26(2):118-22. PubMed ID: 17298737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
    Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M
    Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells.
    Najjar I; Baran-Marszak F; Le Clorennec C; Laguillier C; Schischmanoff O; Youlyouz-Marfak I; Schlee M; Bornkamm GW; Raphaël M; Feuillard J; Fagard R
    J Virol; 2005 Apr; 79(8):4936-43. PubMed ID: 15795279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
    Guasparri I; Bubman D; Cesarman E
    Blood; 2008 Apr; 111(7):3813-20. PubMed ID: 18230756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
    Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.
    Izumi KM; Kaye KM; Kieff ED
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1447-52. PubMed ID: 9037073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
    Vockerodt M; Tesch H; Kube D
    Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.
    Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E
    J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
    Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
    Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.
    Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J
    Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.
    Gires O; Zimber-Strobl U; Gonnella R; Ueffing M; Marschall G; Zeidler R; Pich D; Hammerschmidt W
    EMBO J; 1997 Oct; 16(20):6131-40. PubMed ID: 9359753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
    Mainou BA; Everly DN; Raab-Traub N
    J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
    Fries KL; Miller WE; Raab-Traub N
    Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.
    Thornburg NJ; Kulwichit W; Edwards RH; Shair KH; Bendt KM; Raab-Traub N
    Oncogene; 2006 Jan; 25(2):288-97. PubMed ID: 16247482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
    Thornburg NJ; Raab-Traub N
    J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers.
    Fischer N; Kopper B; Graf N; Schlehofer JR; Grässer FA; Mueller-Lantzsch N
    Virus Res; 1999 Mar; 60(1):41-54. PubMed ID: 10225273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus signal transduction and B-lymphocyte growth transformation.
    Izumi KM
    Prog Mol Subcell Biol; 2004; 36():269-88. PubMed ID: 15171616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EBV latent membrane protein 1 is a negative regulator of TLR9.
    Fathallah I; Parroche P; Gruffat H; Zannetti C; Johansson H; Yue J; Manet E; Tommasino M; Sylla BS; Hasan UA
    J Immunol; 2010 Dec; 185(11):6439-47. PubMed ID: 20980631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.